Laboratoires Thea SA - Company Profile
Powered by 
All the sales intelligence you need on Laboratoires Thea SA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Laboratoires Thea SA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Laboratoires Thea SA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Laboratoires Thea SA (Thea) is a manufacturer of preventive and curative ophthalmologic products. The company develops, manufactures, and markets products such as eye drops, ophthalmic gels, sterile compresses, and micellar solutions in the areas of diagnosis, surgery and therapeutics. The company provides an array of products, both preventive and curative, in the fields of diagnosis, surgery and therapeutics. Thea categorizes its products and research and development based on seven indications, namely: allergy; dry eye; glaucoma; ocular and eyelid infections; eyelid hygiene; eye surgery; and Mydriasis segment.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Thea;s R&D arm focuses on developing therapeutic advancements and new treatment options. The company's R&D initiatives are based on a three-pronged strategy: innovative delivery systems, the development of new active ingredients for eye care, and the improvement of existing products through formulation advancements. The company is committed to providing preservative-free solutions and has achieved over 30 therapeutic innovations in eye health. The R&D efforts are supported by a modern laboratory in Clermont-Ferrand, which has recently expanded to 1,000 square meters. The R&D activities of Théa are managed by an in-house R&D team and Théa Open Innovation (TOI). The in-house R&D team focuses on developing therapeutic innovations and improving existing products. Théa Open Innovation is responsible for attracting external innovation, establishing collaborations, and enhancing new solutions for treating eye diseases. TOI aims to bring new projects to the R&D pipeline, particularly in rare diseases and e-health solutions. Théa has one main R&D center located at its headquarters in Clermont-Ferrand. The company holds several U.S. patents for its products, including ABAK vial, AKTEN, AZASITE, IYUZEH, ZIOPTAN, and ZOLYMBUS. The company has established numerous partnerships in gene and cell therapies, artificial intelligence, and the Internet of Things (IoT) to develop new solutions in eye care.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer